Progress in A Real-world Study of Abiraterone Acetate Versus Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer
The safety and survival benefits of abiraterone acetate and docetaxel in the treatment of patients with metastatic hormone-sensitive prostate cancer have been confirmed by randomized controlled trials and clinical studies abroad. However, real-world studies remain lacking. In this article, we review...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Magazine House of Cancer Research on Prevention and Treatment
2023-05-01
|
| Colecção: | Zhongliu Fangzhi Yanjiu |
| Assuntos: | |
| Acesso em linha: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1152 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|